Abstracts
Gastrointestinal tumours, non-colorectal
618O - Health-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR)

https://doi.org/10.1093/annonc/mdx369.002Get rights and content
Under an Elsevier user license
open archive

Cited by (0)